JaxBio

JaxBioJaxBio
JaxBio

JaxBio

AI-powered blood test for early cancer detection and subtyping.

Website
2021Active13San Francisco, United States
Rate
Advertise here

About

JaxBio develops a simple, fast, and highly sensitive blood test for the early diagnosis of cancer. Their technology utilizes artificial intelligence to probe thousands of cancer-specific biomarkers, enabling the identification of different cancer types and subtypes at various stages. This aims to improve cancer detection, monitoring, and treatment response prediction.

Technology stack

detected 2026-07-13
Email
Hosting
self_managed
Stack
SEO
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does JaxBio do?

JaxBio develops a simple, fast, and highly sensitive blood test for the early diagnosis of cancer. Their technology utilizes artificial intelligence to probe thousands of cancer-specific biomarkers, enabling the identification of different cancer types and subtypes at various stages. This aims to improve cancer detection, monitoring, and treatment response prediction. (formerly JaxBio Technologies.)

How much funding has JaxBio raised?

JaxBio has raised a total of $22M in funding. The most recent round on record is Grant.

Where is JaxBio headquartered?

JaxBio is headquartered in San Francisco, United States.

When was JaxBio founded?

JaxBio was founded in 2021.

What industry does JaxBio operate in?

JaxBio operates in Life Sciences, Biotech, Blood, Biomarkers, Oncology, Cancer.

How many employees does JaxBio have?

JaxBio has approximately 13 people on record.

What is JaxBio's revenue?

StartupHub estimates JaxBio's annual revenue at $2.3M (range $1.2M to $3.5M, 64% confidence), based on comparable companies in the sector.

What is JaxBio's valuation?

StartupHub estimates JaxBio's effective valuation at $87.7M (range $54.3M to $130.4M, 15% confidence), based on comparable companies in the sector.